The pathophysiological significance of IGF-I receptor overexpression: New insights

Pediatric Endocrinology Reviews

Volumn 7, Issue 1, 2009, Pages 2-5

  Werner, Haim ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cancer; Gene expression; IGF 1 receptor; Insulin like Growth Factors (IGF); Transcription factors

Indexed keywords

BRCA1 PROTEIN; GROWTH FACTOR RECEPTOR; GROWTH HORMONE; PLATELET DERIVED GROWTH FACTOR; PROTEIN P53; SOMATOMEDIN; SOMATOMEDIN 1 RECEPTOR; SOMATOMEDIN RECEPTOR; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR;

ANGIOGENESIS; BIOLOGICAL ACTIVITY; BRAIN CANCER; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CANCER RISK; CANCER STAGING; CANCER THERAPY; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL SURVIVAL; DEVELOPMENTAL STAGE; ERYTHROCYTE; GENE LOCUS; GENE MUTATION; GENE OVEREXPRESSION; GENE SYNTHESIS; GENETIC TRANSCRIPTION; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY CANCER; LYMPHOCYTE; MACROCEPHALY; MACROSOMIA; MALIGNANT TRANSFORMATION; NORTHERN BLOTTING; ONCOGENE; ONCOGENE SRC; ONTOGENY; PATHOPHYSIOLOGY; PHENOTYPE; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; ROUS SARCOMA ONCOVIRUS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; GENE EXPRESSION; GENETICS; NEOPLASM;

GENE EXPRESSION; HUMANS; NEOPLASMS; RECEPTOR, IGF TYPE 1; TRANSCRIPTION FACTORS;

EID: 70349567553     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Salmon WD, Daughaday WH. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 1957;49:825-836
2. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 1998;279:563-566 (Pubitemid 28067285)
3. Renehan AG, Zwahlen M, C M, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004;363:1346-1353
4. Yuen JSP, Macaulay VM. Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer. Exp Opinion Ther Targets 2008;12:589-603 (Pubitemid 351699478)
5. Baserga R. The contradictions of the insulin-like growth factor 1 receptor. Oncogene 2000;19:5574-5581
6. Werner H, LeRoith D. The role of the insulin-like growth factor system in human cancer. Adv Cancer Res 1996;68:183-223
7. Eshet R, Werner H, Klinger B, Silbergeld A, Laron Z, LeRoith D, Roberts CT, Jr. Up-regulation of insulin-like growth factor-I (IGF-I) receptor gene expression in patients with reduced serum IGF-I levels. J Mol Endocrinol 1993;10:115-120 (Pubitemid 23100293)
8. Maor S, Mayer D, Yarden RI, Lee AV, Sarfstein R, Werner H, Papa MZ. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1. J Endocrinol 2006;191:605-612 (Pubitemid 46210286)
9. Rubini M, Werner H, Gandini E, Roberts CT, Jr, LeRoith D, Baserga R. Platelet-derived growth factor increases the activity of the promoter of the IGF-I receptor gene. Exp Cell Res 1994;211:374-379
10. Hernandez-Sanchez C, Werner H, Roberts CT, Jr, Woo EJ, Hun DW, Rosenthal SM, LeRoith D. Differential regulation of IGF-I receptor gene expression by IGF-I and basic fibroblast growth factor. J Biol Chem 1997;272:4663-4670
11. Bondy CA, Werner H, Roberts CT, Jr, LeRoith D. Cellular pattern of insulin-like growth factor I (IGF-I) and type I IGF receptor gene expression in early organogenesis: comparison with IGF-II gene expression. Mol Endocrinol 1990;4:1386-1398
12. Bentov I, Werner H. IGF, IGF receptor and overgrowth syndromes. Pediatr Endocrinol Rev 2004;1:352-360
13. Werner H, Roberts CT, Jr. The IGF-I receptor gene: a molecular target for disrupted transcription factors. Genes, Chromosomes and Cancer 2003;36:113-120
14. Schnarr B, Strunz K, Ohsam J, Benner A, Wacker J, Mayer D. Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer. Int J Cancer 2000;89:506-513
15. Maor S, Yosepovich A, Papa MZ, Yarden RI, Mayer D, Friedman E, Werner H. Elevated insulin-like growth factor-I receptor (IGF-IR) levels in primary breast tumors associated with BRCA1 mutations. Cancer Lett 2007;257:236-243 (Pubitemid 47538827)
16. Tennant MK, Thrasher JB, Twomey PA, Drivdahl RH, Birnbaum RS, Plymate SR. Protein and mRNA for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium. J Clin Endocrinol Metab 1996;81:3774-3782
17. Hellawell GO, Turner GD, Davies DR, Poulsom R, Brewster SF, Macaulay VM. Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease. Cancer Res 2002;62:2942-2950
18. Liao Y, Abel U, Grobholz R, Hermani A, Trojan L, Angel P, Mayer D. Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade. Human Pathol 2005;36:1186-1196
19. Abuzzahab MJ, Schneider A, Goddard A, Grigorescu F, Lautier C, Keller E, Kiess W, Klammt J, Kratzsch J, Osgood D, Pfaffle R, Raile K, Seidel B, Smith RJ, Chernausek SD, Group IGRIS. IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. New England J Med 2003;349:2211-2222
20. Faivre L, Gosset P, Comier-Daire V, Odent S, Amiel J, Giurgea L, Nassogne MC, Pasquier L, Munnich A, Romana S, Prieur M, Vekemans M, De Blois MC, Turleau C. Overgrowth and trisomy 15q26.1-qter including the IGF1 receptor gene: report of two families and review of the literature. Eur J Hum Genet 2002;10:699-706
21. Peoples R, Milatovich A, Francke U. Hemizygosity at the insulin-like growth factor I receptor (IGF1R) locus and growth failure in the ring chromosome 15 syndrome. Cytogenet Cell Genetics 1995;70:228-234
22. Peterson JE, Jelinek T, Kaleko M, Siddle K, Weber MJ. C phosphorylation and activation of the IGF-I receptor in src-transformed cells. J Biol Chem 1994;269:27315-27321 (Pubitemid 24346553)
23. Reiss K, Ferber A, Travail S, Porcu P, Phillips PD, Baserga R. The protooncogene c-myb increases the expression of insulin-like growth factor I and insulin-like growth factor I receptor messenger RNAs by a transcriptional mechanism. Cancer Res 1991;51:5997-6000
24. Abramovitch S, Glaser T, Ouchi T, Werner H. BRCA1-Sp1 interactions in transcriptional regulation of the IGF-IR gene. FEBS Lett 2003;541:149-154 (Pubitemid 36428934)
25. Schayek H, Haugk K, Sun S, True LD, Plymate SR, Werner H. Tumor suppressor BRCA1 is expressed in prostate cancer and control IGF1-R gene transcription in an androgen receptor-dependent manner. Clin Cancer Res 2009;15:1558-1565
26. Yuen JSP, Cockman ME, Sullivan M, Protheroe A, Turner GDH, Roberts IS, Pugh CW, Werner H, Macaulay VM. The VHL tumor suppressor inhibits expression of the IGF1R and its loss induces IGF1R upregulation in human clear cell renat carcinoma. Oncogene 2007;26:6499-6508
27. Werner H, Karnieli E, Rauscher FJ, III, LeRoith D. Wild type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc Natl Acad Sci USA 1996;93:8318-8323
28. Idelman G, Glaser T, Roberts CT, Jr, Werner H. WT1-p53 interactions in IGF-I receptor gene regulation. J Biol Chem 2003;278:3474-3482
29. Nahor I, Abramovitch S, Engeland K, Werner H. The p53-family members p63 and p73 inhibit insulin-like growth factor-I receptor gene expression in colon cancer cells. Growth Hormone IGF Res 2005;15:388-396
30. Werner H, Maor S. The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor action. Trends Endocrinol Metab 2006;17:236-242 (Pubitemid 44080616)